1,853 material Form 8-K filings that 1,500 companies we cover made with the SEC in September 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Stoneridge appointed Uwe Brandenburg as Global Vice President, Engineering & Innovation, effective November 2, 2026, under an employment agreement dated September 17, 2026. He will report to CEO Natalia Noblet and lead the company's global engineering organization, and he will serve on the Executive Team.
Annual base salary of €320,000 (about $367,168), with a target bonus of 50% of base salary
One-time special equity grant of $150,000 in time-based Stoneridge shares, vesting ratably over three years
Previously Chief Technology Officer and Senior Vice President, Automotive and Manufacturing at DXC Technology (formerly Luxoft)
Plug Power said Chief Operating Officer Dean C. Fullerton will resign effective October 23, 2026, to accept a position at another company, having notified the company on September 17, 2026. The filing says the resignation was not due to any disagreement with the company on its operations, policies or practices, and that his duties will move to certain Executive Vice Presidents and Vice Presidents, with Fullerton assisting the transition.
Dean C. Fullerton, Chief Operating Officer, notified the company on September 17, 2026 of his resignation
Resignation takes effect October 23, 2026
Filing states no disagreement with the company on operations, policies or practices
Duties will transfer to certain Executive Vice Presidents and Vice Presidents
TransUnion said Chief Financial Officer Todd Cello will resign effective December 31, 2026, after 29 years with the company, including nine years as CFO. He will serve as a full-time advisor through March 1, 2027, and the company has begun a search for a successor, with an interim CFO expected if no replacement is hired by the transition date. TransUnion also reaffirmed its third quarter and full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted Earnings Per Share, and said the departure is not expected to affect operations or long-term financial targets.
Todd Cello resigns as EVP and CFO effective December 31, 2026; he is not leaving over a disagreement with the company
Cello provides transition services through March 1, 2027; the company's search for a successor is underway
Transition agreement dated September 23, 2026 includes salary through March 1, 2027 and a 2026 annual bonus, subject to performance and employment through the transition date, plus COBRA coverage of up to 18 months and outplacement services
TransUnion reaffirmed third quarter and full-year 2026 guidance for revenue, Adjusted EBITDA and Adjusted Diluted EPS
Wells Fargo said on September 23, 2026 that Scott E. Powell will become its Chief Risk Officer effective January 15, 2027. After that date he will no longer serve as the company's Chief Operating Officer. The filing does not describe the reasons for the change or any compensation terms.
Scott E. Powell appointed Chief Risk Officer, effective January 15, 2027
Powell will no longer serve as Chief Operating Officer after that date
Announced September 23, 2026 in an SEC Form 8-K under Item 5.02
Five Below's board increased its size from nine to ten directors and elected Scott Settersten, former Chief Financial Officer of Ulta Beauty, effective September 21, 2026, with a seat on the Audit Committee. The filing says the board considers him independent, and he received an initial grant of 545 restricted stock units that vests at the next annual shareholder meeting.
Scott Settersten elected September 21, 2026; board expanded from nine to ten directors
Served as CFO of Ulta Beauty from 2012 until retiring in March 2024; previously 15 years at PricewaterhouseCoopers LLP
Initial grant of 545 restricted stock units; term runs until the 2027 annual shareholder meeting
Unity Bancorp said CEO James A. Hughes will retire effective March 31, 2027, and President George Boyan will become CEO effective April 1, 2027, under a planned succession process. Hughes will remain on the boards of the Company and Unity Bank. The company also amended Hughes' retirement plan, raising his benefit percentage from 60% to 65%, which will produce a one-time pre-tax expense of $769 thousand in the quarter ending September 30, 2026.
James A. Hughes retires as CEO effective March 31, 2027, and will continue as a director of the Company and Unity Bank
George Boyan, President since January 1, 2026, becomes CEO effective April 1, 2027
SERP amendment raises Hughes' retirement benefit from 60% to 65% of the compensation measure, with a one-time pre-tax expense of $769 thousand in the quarter ending September 30, 2026
Galaxy Digital said its Chief Accounting Officer, Robert Rico, will resign effective September 30, 2026, to pursue an outside opportunity. The board appointed Dritan Muneka, the company's Head of Accounting Policy since May 2022, as principal accounting officer with the title Corporate Controller, effective on the same date. The change is an orderly internal succession in a key finance role, and the filing reports no financial figures.
Robert Rico resigns as Chief Accounting Officer and principal accounting officer effective September 30, 2026; he notified the company on August 5, 2026
Board appointed Dritan Muneka on September 22, 2026, as principal accounting officer with the title Corporate Controller
Muneka previously worked at KPMG LLP from November 2010 to April 2022, ending as Managing Director, and is a certified public accountant
Flywire Corporation's board appointed Sabrina Farmer as a Class II director on September 22, 2026, increasing the board from nine to ten members. She also joined the Nominating and Corporate Governance Committee, and the filing describes her as independent under Nasdaq rules. The filing reports no financial results, and the board change itself does not include financial figures beyond her director pay.
Board appointed Sabrina Farmer on September 22, 2026; her initial term expires at the 2029 annual meeting.
Board size increased from nine to ten directors.
Annual cash retainer of $35,000 for board service plus $4,000 for Nominating and Corporate Governance Committee service.
Initial restricted stock unit award with a fair market value of $350,000, vesting in three equal annual installments, and an annual award of $175,000 tied to annual meetings.
Central Plains Bancshares (CPBI) disclosed that the board of its subsidiary, Home Federal Savings and Loan Association of Grand Island, extended the employment and change in control agreements for its CEO and two executive officers. The terms now expire on October 24, 2029, and the filing states no other changes were made to the agreements.
On September 22, 2026, the board extended the employment agreement with CEO Dannel R. Garness.
Change in control agreements for CFO Bradley M. Kool and Chief Lending Officer Kurt A. Haecker were also extended.
All extended agreements now expire on October 24, 2029.
The filing states there were no other changes to the agreements.
Edgewell Personal Care said LaTanya Langley will become Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026, and will leave her Chief People Officer role on the same date. The filing states there are no changes to her compensation tied to these role changes.
Role change effective October 1, 2026, determined by the company on September 17, 2026
Langley will no longer serve as Chief People Officer as of October 1, 2026
No change to Langley's compensation in connection with the role changes
Corcept Therapeutics said Sean Maduck, President of its Endocrinology division, will retire effective October 1, 2026, and Justin Gunn will succeed him. Maduck will stay on as a consultant under an agreement paying $57,000 per month, and the company said he did not resign because of any disagreement with the company. The filing does not include financial results or guidance changes, so the direct effect on shareholders is limited to the leadership change.
Sean Maduck notified the board on September 22, 2026 of his decision to resign effective October 1, 2026.
Maduck's consulting agreement runs through September 30, 2027, with a cash fee of $57,000 per month, and his outstanding stock options continue to vest.
Justin Gunn joined Corcept in July 2024 as Vice President of Sales and Commercial Learning for the Oncology division and will report to CEO Joseph K. Belanoff, M.D.
MeiraGTx appointed Alan M. Sebulsky to its Board of Directors as a Class I director, effective September 23, 2026, and named him to the Science and Technology Committee. Mr. Sebulsky previously spent about 14 years as a Partner and Portfolio Manager at Adage Capital Management, where he managed a biopharmaceutical portfolio, and the company said he brings healthcare investment experience as it transitions to a commercial company.
Board appointment effective September 23, 2026; term runs to the 2028 annual meeting of shareholders
Mr. Sebulsky joins the Science and Technology Committee
Previously Partner and Portfolio Manager at Adage Capital Management from July 2012 to April 2026; Managing Member of Apothecary Capital LLC since April 2026
Company states there are no related party transactions with Mr. Sebulsky
Angi said on September 22, 2026 that board member Michael Steib succeeds Jeff Kip as chief executive, and that Joey Levin stepped down as Executive Chairman and executive officer to become Chairman and remain an employee. The board was reduced by one seat to nine members. The filing gives Steib a $1.00 annual base salary, no cash incentive, and equity awards covering 2,000,000 shares, which matters to shareholders because it sets the terms of the new CEO's pay and dilution.
Steib became CEO effective September 22, 2026; he has been a board member since August 2026 and was TEGNA's president and CEO from August 2024 to May 2026.
Steib's employment agreement sets a $1.00 annual base salary, no cash incentive, a 1,000,000-share RSU award, and a 1,000,000-share PSU award tied to stock price hurdles from $10.00 to $20.00.
Kip receives an additional $325,000 cash payment and will consult for the company through March 22, 2027.
Levin remains Chairman and an employee, and the board size was reduced to nine members.
Boston Scientific said Executive Vice President and Group President Arthur C. Butcher will retire from his role on January 1, 2027, and remain as a senior advisor through February 26, 2027. The filing says the company expects a retirement agreement with payments and benefits materially consistent with his existing plan terms.
Butcher informed the company of his retirement decision on September 21, 2026.
He leads MedSurg and Asia Pacific as Group President; retirement is effective January 1, 2027.
As senior advisor, his current annual base salary is $780,000, prorated through the Retirement Date.
The Retirement Date is February 26, 2027, or any earlier date.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.